Effect of low-intensity long-duration ultrasound on the symptomatic relief of knee osteoarthritis: a randomized, placebo-controlled double-blind study

被引:29
|
作者
Draper, David O. [1 ]
Klyve, Dominic [2 ]
Ortiz, Ralph [4 ]
Best, Thomas M. [3 ]
机构
[1] Brigham Young Univ, Dept Exercise Sci, 106 SFH, Provo, UT 84602 USA
[2] Cent Washington Univ, Dept Math, Ellensburg, WA USA
[3] Univ Miami, UHlth Sports Performance & Wellness Inst, Coral Gables, FL 33124 USA
[4] Med Pain Consultants, Dryden, NY USA
来源
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH | 2018年 / 13卷
关键词
Osteoarthritis; Pain; Low-intensity ultrasound; Knee; Long duration; Musculoskeletal; Sustained acoustic medicine; THERAPEUTIC ULTRASOUND; PULSED ULTRASOUND; METAANALYSIS; MANAGEMENT; ARTHRITIS; PAIN; HIP;
D O I
10.1186/s13018-018-0965-0
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
BackgroundWearable long-duration low-intensity ultrasound is an emerging non-invasive and non-narcotic therapy for the daily treatment of musculoskeletal pain. The aim of this randomized, double-blind, placebo-controlled study was to examine whether long-duration low-intensity ultrasound was effective in treating pain and improving function in patients with knee osteoarthritis.MethodsNinety patients with moderate to severe knee pain and radiographically confirmed knee osteoarthritis (Kellgren-Lawrence grade I/II) were randomized for treatment with active (n=55) or placebo (n=35) devices applied daily to the treated knee. Investigators and subjects were blinded to treatment groups. Ultrasound (3MHz, 0.132W/cm(2), 1.3W) was applied with a wearable device for 4h daily for 6weeks, delivering 18,720J per treatment. The primary outcome was change in pain intensity (numeric rating scale) assessed prior to intervention (baseline) and after 6weeks. Secondary outcomes of functional change were measured at baseline and after 6weeks using the Western Ontario McMaster Osteoarthritis Questionnaire (n=84), along with range of motion (flexion, extension) and isometric muscle strength (flexion, extension and rotation) tests on the injured knee in a small pilot subset (n=17).ResultsThe study had a 93% retention rate, and there were no significant differences between the groups regarding demographic variables or baseline outcome measures. Patients treated with active therapy observed a significant mean NRS pain reduction over the 6-week study of 1.96 points for active (p<0.0001), compared with a 0.85 points reduction for placebo (p=0.13). The functional score was also significantly improved by 505 points for the active group over the 311-point improvement for placebo group compared to baseline (p=0.02). In the pilot subset evaluated, rotational strength increased from baseline to 6weeks (3.2N, p=0.03); however, no other measures were significant.ConclusionsLong-duration low-intensity ultrasound significantly reduced pain and improved joint function in patients with moderate to severe osteoarthritis knee pain. The clinical findings suggest that ultrasound may be used as a conservative non-pharmaceutical and non-invasive treatment option for patients with knee osteoarthritis. Additional research is warranted on non-weight bearing joints of the musculoskeletal system as well as extended treatment time frames and follow-up.Trial registrationNCT02083861, registered 11 March 2014, https://clinicaltrials.gov/ct2/show/results/NCT02083861
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Short-Term Effect of a New Oral Sodium Hyaluronate Formulation on Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Cicero, Arrigo F. G.
    Girolimetto, Nicolo
    Bentivenga, Crescenzio
    Grandi, Elisa
    Fogacci, Federica
    Borghi, Claudio
    DISEASES, 2020, 8 (03)
  • [42] Randomized, Double-Blind, Placebo-Controlled Trial of Intraarticular Trans-Capsaicin for Pain Associated With Osteoarthritis of the Knee
    Stevens, Randall M.
    Ervin, John
    Nezzer, Jennifer
    Nieves, Yeni
    Guedes, Kimberly
    Burges, Robin
    Hanson, Peter D.
    Campbell, James N.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (09) : 1524 - 1533
  • [43] Effects of PEMF on Patients With Osteoarthritis: Results of a Prospective, Placebo-Controlled, Double-Blind Study
    Wuschech, Heinz
    von Hehn, Ulrike
    Mikus, Eberhard
    Funk, Richard H.
    BIOELECTROMAGNETICS, 2015, 36 (08) : 576 - 585
  • [44] Golden plaster for pain therapy in patients with knee osteoarthritis: study protocol for a multicenter randomized, double-blind, placebo-controlled trial
    Liu, Jin-Tao
    Tang, De-Zhi
    Li, Xiao-Feng
    Zhang, Zhi-Gang
    Ji, Wan-Bo
    Tao, Shuai
    Wang, Yong-Jun
    Jiang, Hong
    TRIALS, 2013, 14
  • [45] Efficacy of natural eggshell membrane for knee osteoarthritis: A randomized, double-blind, placebo-controlled clinical trial
    Park, Sohyeon
    Ko, Seong-Hwan
    Yoon, Nam-Kyu
    Kim, Byung-Kwon
    Kim, Jongkyu
    Kang, Eun-Bum
    Oh, Minseok
    Son, Chang-Gue
    Lee, Eun-Jung
    JOURNAL OF FUNCTIONAL FOODS, 2024, 121
  • [46] A randomized, double-blind, placebo-controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis
    Prior, Mary Jane
    Harrison, Diane D.
    Frustaci, Mary Ellen
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (11) : 2377 - 2387
  • [47] Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial
    Rossini, Maurizio
    Adami, Silvano
    Fracassi, Elena
    Viapiana, Ombretta
    Orsolini, Giovanni
    Povino, Maria Rosaria
    Idolazzi, Luca
    Gatti, Davide
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (02) : 255 - 263
  • [48] Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial
    Pramhas, Sibylle
    Thalhammer, Teresa
    Terner, Sebastian
    Pickelsberger, Daniel
    Gleiss, Andreas
    Sator, Sabine
    Kress, Hans G.
    LANCET REGIONAL HEALTH-EUROPE, 2023, 35
  • [49] A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritis
    Piet Geusens
    Karel Pavelka
    Jozef Rovensky
    Johan Vanhoof
    Nathalie Demeester
    Mario Calomme
    Dirk Vanden Berghe
    BMC Musculoskeletal Disorders, 18
  • [50] Celecoxib versus diclofenac in the management of osteoarthritis of the knee - A placebo-controlled, randomised, double-blind comparison
    McKenna, F
    Borenstein, D
    Wendt, H
    Wallemark, C
    Lefkowith, JB
    Geis, GS
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2001, 30 (01) : 11 - 18